↓ Skip to main content

Cochrane Database of Systematic Reviews

Toremifene versus tamoxifen for advanced breast cancer

Overview of attention for article published in Cochrane database of systematic reviews, July 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
7 X users
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
119 Mendeley
Title
Toremifene versus tamoxifen for advanced breast cancer
Published in
Cochrane database of systematic reviews, July 2012
DOI 10.1002/14651858.cd008926.pub2
Pubmed ID
Authors

Chen Mao, Zu-Yao Yang, Ben-Fu He, Shan Liu, Jun-Hua Zhou, Rong-Cheng Luo, Qing Chen, Jin-Ling Tang

Abstract

Toremifene (TOR) and tamoxifen (TAM) can both be used as treatments for advanced breast cancer.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 119 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 11%
Researcher 12 10%
Student > Ph. D. Student 8 7%
Student > Bachelor 7 6%
Other 7 6%
Other 17 14%
Unknown 55 46%
Readers by discipline Count As %
Medicine and Dentistry 29 24%
Nursing and Health Professions 12 10%
Biochemistry, Genetics and Molecular Biology 7 6%
Agricultural and Biological Sciences 6 5%
Psychology 4 3%
Other 7 6%
Unknown 54 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 November 2021.
All research outputs
#4,723,228
of 25,838,141 outputs
Outputs from Cochrane database of systematic reviews
#7,014
of 13,141 outputs
Outputs of similar age
#30,785
of 178,813 outputs
Outputs of similar age from Cochrane database of systematic reviews
#95
of 179 outputs
Altmetric has tracked 25,838,141 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,141 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 178,813 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 179 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.